Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Clever Leaves Holdings Inc. - Common Shares (NQ: CLVR )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, May 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Clever Leaves Holdings Inc. - Common Shares

< Previous 1 2 3 4 5 6 Next >
63 Biggest Movers From Yesterday
Gainers InMed Pharmaceuticals Inc. (NASDAQ: INM) shares gained 39.1% to close at $1.05 on Thursday. The company recently said its CFO Bruce Colwill will retire. Global Internet... 
Via Benzinga
Here's Why Cannabis-Related Stock Clever Leaves Is Rising During Thursday's After-Hours Session
Clever Leaves Holdings Inc (NASDAQ:CLVR) shares are tradin... 
Via Benzinga
A Preview Of Clever Leaves Holdings's Earnings
Clever Leaves Holdings (NASDAQ:CLVR) is set to give its latest quarterly earnings report on Thursday, 2022-03-24. Here's what investors need to know before the announcement.... 
Via Benzinga
Earnings Scheduled For March 24, 2022
Companies Reporting Before The Bell • iHuman (NYSE:IH) is likely to report earnings for its fourth quarter. • Pioneer Muni High Inc (NYSE:MAV) is expected to... 
Via Benzinga
InterCure And Clever Leaves Enter Into International Strategic Partnership
InterCure Ltd. (NASDAQ:INCR) (TSX: 
Via Benzinga
Clever Leaves Teams Up With FoliuMed To Import Colombian Cannabis EU-GMP Bulk Extracts Into Germany
Clever Leaves Holdings Inc. (NASDAQ:CLVR) has sign... 
Via Benzinga
Clevers Leaves Inks $7.8M Product Deal With Australian Medical Cannabis Company
Clever Leaves Holdings Inc. (NASDAQ:CLVR) has inke... 
Via Benzinga
Clever Leaves Expands Partnership With German Cannabis Distributor Cansativa On Heels Of $15M Raise
Clever Leaves Holdings Inc. (NASDAQ:CLVR) is expanding its... 
Via Benzinga
Clever Leaves' Pharmaceutical-Grade Cannabis Extracts Reach Germany Via Ethypharm Partnership
Pharmaceutical-grade cannabinoids extracts produced by Clever Leaves Holdings Inc. (NASDAQ: 
Via Benzinga
Cannabis Movers & Shakers: Ascend Wellness, MedMen, Clever Leaves, Palo Santo, GoldCann
Ascend Wellness Promotes Frank Perullo To President Ascend Wellness Holdings, Inc. (CSE: 
Via Benzinga
Clever Leaves Expands Deal With Cannatrek In Australia Via $3.6M Sales Agreement To Include THC Flower
Clever Leaves Holdings Inc. (NASDAQ:CLVR) announced an 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 115 companies reached new 52-week lows. Noteworthy Points From Today's 52-Week Lows: The largest company by market cap to hit a new 52-week low... 
Via Benzinga
78 Biggest Movers From Friday
Gainers Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) surged 26% to close at $2.24. Y-mAbs reported completion of pre-BLA meeting with the FDA for Omburtamab. China Online Education... 
Via Benzinga
The Week In Cannabis: Schumer's Bill, The Super Bowl, Leafly, Canopy Growth, Tilray, Hexo, Sundial And More
Below is a recap of the main news related to the cannabis industry and markets for the week of February 7, 2022. Contents 
Via Benzinga
Clever Leaves' Q4 Revenue Up 25% YoY, Introduces 2022 Outlook & New CEO
Clever Leaves Holdings Inc. (NASDAQ: CLVR) reported its preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2021, along with its 2022 outlook. 
Via Benzinga
The "Cannabis 50" List For 2021 Is Out, Is Your Favorite Company On It?
MGO (Macias Gini and O’Connell LLP), a leader in accounting, tax, audit and advisory solutions for the cannabis and hemp industries has released its 3rd annual “Cannabis 50” list. 
Via Benzinga
Clever Leaves Enters US Consumer CBD Market Via Herbal Brands' JoySol
Clever Leaves Holdings Inc. (NASDAQ: CLVR), a multinational operator and li... 
Via Benzinga
10 Biggest Price Target Changes For Thursday
Barclays lifted the price target on Cintas Corporation (NASDAQ: CTAS) from $470 to $500. Cintas shares rose 1.2% to $434.11 in pre-market trading. Ascendiant Capital cut... 
Via Benzinga
The Week In Cannabis: Earnings Season, A GOP Legalization Bill, Seth Rogen & Sarah Silverman's Campaign
Below is a recap of the main news related to the cannabis industry and markets for the week of November 8, 2021. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
65 Biggest Movers From Yesterday
Gainers Brickell Biotech, Inc. (NASDAQ: BBI) shares jumped 58.6% to settle at $0.33 on Tuesday after HC Wainwright & Co initiated coverage on the stock with a Buy rating and... 
Via Benzinga
Benzinga Exclusive Interview: Europe's Cannabis Market Projected to Grow by 400% And Companies Are Already Taking a Huge Bite of This Opportunity
Photos by Clever Leaves The following post was written and/or published as a collaboration between Benzinga’s in-house... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Stocks That Hit 52-Week Lows On Friday
Before 10 am on Friday, 110 companies set new 52-week lows. Interesting Points From Today's 52-Week Lows: Humana (NYSE:HUM) was the biggest company on a market cap... 
Via Benzinga
Clever Leaves Reports Third Quarter 2021 Results, Continues Expansion
Clever Leaves Holdings Inc. (NASDAQ:CLVR) (NASDAQ: 
Via Benzinga
The Week In Cannabis: Canopy's Earnings, JPMorgan's Restrictions, A Slew Of Earnings, Big Policy Moves
Below is a recap of the main news related to the cannabis industry and markets for the week of November 1st, 2021. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
EXCLUSIVE: Brazilian Regulators Approve CBD Medication, University To Study Its Effectiveness Against Long-Haul COVID-19
In a major regulatory win for the entire cannabis industry, the stringent Brazilian Health Regulatory Agency (Anvisa) has ... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
International Spotlight - Continued Cannabis Expansion in European Markets
During Benzinga Cannabis Capital Conference, several leaders of various cannabis companies gathered to discuss the co... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Clever Leaves Confirms Its First Commercial Export Of THC Flower From Portugal To The U.S.
Clever Leaves Holdings Inc. (NASDAQ:CLVR) confirmed Wednes... 
Via Benzinga
Clever Leaves is Advancing Research into Cannabis for Chronic Disease Treatment with "Project Change Lives"
Image Provided by Clever Leaves For years, cannabinoids, the chemicals found in the cannabis plant, have been widely known for their therapeutic and medicinal abilities.... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
What Will Be The Cost Of Doing Cannabis Business in Mexico...If The Country Finally Legalizes It?
Medical marijuana has been legalized in Mexico since June 2017 and, in 2018, Mexico’s Supreme Court of Justice 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Clever Leaves to Present at Upcoming September Investor Conferences
NEW YORK, NY / ACCESSWIRE / August 30, 2021 / Clever Leaves Holdings Inc. (Nasdaq:CLVR) ("Clever Leaves" or the "Company"), a leading multinational operator and licensed producer of... 
From Clever Leaves Holdings Inc.
Via AccessWire
Topics Cannabis
Exposures Cannabis
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.